Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer

NCT01591122 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

313

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Placebo and prednisone
DRUG: Abiraterone acetate and prednisone

Sponsor

Janssen Research & Development, LLC